Matthew A. Wanat

479 total citations
47 papers, 303 citations indexed

About

Matthew A. Wanat is a scholar working on Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matthew A. Wanat has authored 47 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 14 papers in Geriatrics and Gerontology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matthew A. Wanat's work include Opioid Use Disorder Treatment (15 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Innovations in Medical Education (9 papers). Matthew A. Wanat is often cited by papers focused on Opioid Use Disorder Treatment (15 papers), Pharmaceutical Practices and Patient Outcomes (14 papers) and Innovations in Medical Education (9 papers). Matthew A. Wanat collaborates with scholars based in United States, Russia and Australia. Matthew A. Wanat's co-authors include J. Douglas Thornton, Kevin W. Garey, Marc L. Fleming, Susan Abughosh, Wayne L. Chandler, Kevin R. Donahue, Faisal Masud, James E. Muntz, Elizabeth A. Coyle and Anne M. Tucker and has published in prestigious journals such as BMC Public Health, BMC Health Services Research and Otolaryngology.

In The Last Decade

Matthew A. Wanat

39 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Wanat United States 11 109 92 60 56 56 47 303
Ethem Kavukçu Türkiye 9 119 1.1× 20 0.2× 39 0.7× 9 0.2× 17 0.3× 24 276
Monique Lloyd United States 6 68 0.6× 22 0.2× 31 0.5× 14 0.3× 33 0.6× 15 277
Syed Hamza Mufarrih United States 10 27 0.2× 84 0.9× 143 2.4× 8 0.1× 4 0.1× 38 321
Leva Azadi Australia 7 70 0.6× 165 1.8× 43 0.7× 14 0.3× 5 0.1× 9 329
Stéphanie Parat France 8 33 0.3× 16 0.2× 24 0.4× 3 0.1× 98 1.8× 20 275
Linda Morris United States 9 18 0.2× 9 0.1× 89 1.5× 13 0.2× 10 0.2× 23 248
Takashi Shiga Japan 9 52 0.5× 18 0.2× 38 0.6× 8 0.1× 2 0.0× 31 213
Elizabeth A. Bryant United States 8 62 0.6× 30 0.3× 97 1.6× 49 0.9× 20 213
Rebecca Paterson Australia 12 16 0.1× 9 0.1× 52 0.9× 12 0.2× 6 0.1× 26 318

Countries citing papers authored by Matthew A. Wanat

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Wanat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Wanat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Wanat more than expected).

Fields of papers citing papers by Matthew A. Wanat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Wanat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Wanat. The network helps show where Matthew A. Wanat may publish in the future.

Co-authorship network of co-authors of Matthew A. Wanat

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Wanat. A scholar is included among the top collaborators of Matthew A. Wanat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Wanat. Matthew A. Wanat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thornton, J. Douglas, Ekere James Essien, Matthew A. Wanat, et al.. (2025). Addressing wholesale distributor barriers to buprenorphine access: Consensus recommendations from the PhARM-OUD expert panel. Drug and Alcohol Dependence Reports. 16. 100360–100360.
2.
3.
Thornton, J. Douglas, et al.. (2023). Identifying predictors of generalized anxiety among student pharmacists in response to the COVID-19 pandemic. Currents in Pharmacy Teaching and Learning. 15(1). 34–42. 2 indexed citations
4.
Wanat, Matthew A., et al.. (2023). Impact of diversity/life experience scores on the demographic makeup of pharmacy students. Currents in Pharmacy Teaching and Learning. 15(5). 468–472.
5.
Wanat, Matthew A., et al.. (2023). Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey. International Journal of Drug Policy. 116. 104045–104045. 7 indexed citations
6.
Wanat, Matthew A., et al.. (2023). Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study. BMC Public Health. 23(1). 728–728. 1 indexed citations
7.
Thornton, J. Douglas, et al.. (2023). Student-led podcasts to enhance literature evaluation skills. Currents in Pharmacy Teaching and Learning. 15(11). 968–973. 3 indexed citations
8.
Thornton, J. Douglas, et al.. (2022). Evaluation of Discharge Opioid Prescribing in Coronary Artery Bypass Patients Following an Opioid Stewardship Intervention for Providers. Journal of Pharmacy Practice. 36(5). 1077–1084. 2 indexed citations
9.
Wanat, Matthew A.. (2021). Completing the Academic Leadership Fellows Program During the Pandemic. American Journal of Pharmaceutical Education. 86(7). 8855–8855.
10.
Garey, Kevin W., et al.. (2020). A survey to assess experiences and social support of underrepresented minority doctor of pharmacy students. Currents in Pharmacy Teaching and Learning. 13(3). 245–254. 8 indexed citations
11.
Nguyen, Dat, et al.. (2020). Bempedoic Acid: A New Drug for an Old Problem. Annals of Pharmacotherapy. 55(2). 246–251. 9 indexed citations
12.
Wanat, Matthew A., et al.. (2020). Knowledge and self-perception comparisons between students with and without prior technician experience in community pharmacy lab courses. Currents in Pharmacy Teaching and Learning. 13(3). 279–287. 1 indexed citations
13.
Donahue, Kevin R., et al.. (2019). Management of Anticoagulation with Impella® Percutaneous Ventricular Assist Devices and Review of New Literature. Journal of Thrombosis and Thrombolysis. 48(2). 284–291. 23 indexed citations
14.
15.
16.
Wanat, Matthew A., Xin Wang, Rutugandha Paranjpe, et al.. (2019). Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study. Research and Practice in Thrombosis and Haemostasis. 3(4). 674–683. 9 indexed citations
17.
Fleming, Marc L., Larry Driver, Sujit S. Sansgiry, et al.. (2016). Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Research in Social and Administrative Pharmacy. 13(3). 503–512. 10 indexed citations
18.
Fleming, Marc L., Larry Driver, Sujit S. Sansgiry, et al.. (2016). PREDICTING TEXAS PHYSICIANS’ INTENTION TO PRESCRIBE HYDROCODONE COMBINATION PRODUCTS AFTER RESCHEDULING. Value in Health. 19(3). A258–A258. 1 indexed citations
19.
Wanat, Matthew A., Anne M. Tucker, & Elizabeth A. Coyle. (2016). A Critical Care Hybrid Online Elective Course for Third-Year Pharmacy Students. American Journal of Pharmaceutical Education. 80(9). 154–154. 10 indexed citations
20.
Wanat, Matthew A., et al.. (2014). Education, Training, and Academic Experience of Newly Hired, First-Time Pharmacy Faculty Members. American Journal of Pharmaceutical Education. 78(5). 92–92. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ethem Kavukçu Breakdown of academic impact, for papers by Monique Lloyd Breakdown of academic impact, for papers by Syed Hamza Mufarrih Breakdown of academic impact, for papers by Leva Azadi Breakdown of academic impact, for papers by Stéphanie Parat Breakdown of academic impact, for papers by Linda Morris Breakdown of academic impact, for papers by Takashi Shiga Breakdown of academic impact, for papers by Elizabeth A. Bryant Breakdown of academic impact, for papers by Rebecca Paterson
Rankless by CCL
2026